Handheld reflectance confocal microscopy with radial video mosaicing showed utility in mapping lentigo maligna and lentigo maligna melanoma.The prospective trial included patients with biopsy ...

[8,17] The potential risk of an in situ lentigo maligna becoming an invasive melanoma is unknown. There are no long-term follow-up studies so the frequency of progression remains uncertain.

A research team has developed a diagnostic system that uses artificial intelligence (AI) to accurately identify the type of facial pigmented lesions and support laser treatment decisions. A paper on ...

The strongest predictor of lentigo maligna melanoma progression is histologic margin status, and patients with margins less than 3 mm should consider re-excision, according to a study.“Lentigo ...

Sunday, April 20, 2025. News & Perspective Drugs & Diseases CME & Education Video Decision Point close ...

Noting that local excision of lentigo maligna with a margin of 5 mm has recurrence rates ranging from 6 to 20 percent, K. de Vries, from the University Medical Center Groningen in the Netherlands ...

Often confirmed as lentigo maligna melanoma: Amelanotic/NMSC-like (CL3) • Diagnosis as malignant melanoma in situ: less likely • Diagnosis as nodular melanoma or other subtype: more likely ...

SKIN cancer rates are on the rise due to an increase in unprotected sun exposure. For one type - lentigo maligna melanoma - freckles on the face could be a sign.

Carbon Dioxide Laser Treatment for Lentigo Maligna: A Retrospective Review Comparing 3 Different Treatment Modalities. Archives of Facial Plastic Surgery , 2011; 13 (6): 398 DOI: 10.1001 ...

For patients with lentigo maligna (LM) in-situ melanoma, topical imiquimod has a pathological complete regression (pCR) rate of 37%, according to a study published online in the British Journal of ...

Surgical excision for people with lentigo maligna: For people with lentigo maligna (stage 0 in sun damaged skin, usually on the face) how effective is Mohs micrographic surgery, compared with excision ...